| Members |
targetComponentId |
| [X]Personality disorder: [emotionally unstable] or [aggressive] or [borderline] or [explosive] |
Emotionally unstable personality disorder |
| [X]Sequelae of other specified infectious and parasitic diseases (disorder) |
Post-infectious disorder |
| [X]Sequelae of unspecified infectious and parasitic disease (disorder) |
Post-infectious disorder |
| [X]Sibling: [rivalry disorder] or [jealousy] (disorder) |
Sibling jealousy |
| [X]Specific developmental disorder of motor function (& [co-ordination disorder] or [dyspraxia] or [clumsy child syndrome]) (disorder) |
troubles du développement d'une fonction motrice |
| [X]Specific developmental disorder of motor function (& [co-ordination disorder] or [dyspraxia] or [clumsy child syndrome]) (disorder) |
Apraxia, developmental |
| [X]Specific developmental disorder of motor function (& [co-ordination disorder] or [dyspraxia] or [clumsy child syndrome]) (disorder) |
Developmental coordination disorder |
| [X]Teicoplanin adverse reaction (event) |
Teicoplanin adverse reaction |
| [X]Teicoplanin adverse reaction |
Teicoplanin adverse reaction |
| [X]Topical hydrocortisone adverse reaction (event) |
Hydrocortisone adverse reaction (disorder) |
| [X]Topical hydrocortisone adverse reaction (event) |
Hydrocortisone sensitivity |
| [X]Topical hydrocortisone adverse reaction |
Hydrocortisone adverse reaction (disorder) |
| [X]Topical hydrocortisone adverse reaction |
Hydrocortisone sensitivity |
| [X]solvents: [mental & behavioural disorders dependence syndrome due to use of] or [drug addiction] (disorder) |
Glue sniffing dependence |
| a |
Tumor staging descriptor a (tumor staging) |
| a.m. peak specimen (specimen) |
a.m. peak specimen (qualifier value) |
| Abciximab 2mg/mL injection solution 5mL vial (product) |
Product containing precisely abciximab 2 milligram/1 milliliter conventional release solution for injection (clinical drug) |
| Pilonidal sinus with abscess |
abcès de la peau et/ou du tissu sous-cutané causé par un poil incarné (trouble) |
| Pilonidal sinus with abscess |
Hair sinus |
| absence d'évaluation des risques personnels |
évaluation des risques |
| Aircraft crash while taking off, occupant of spacecraft injured (event) |
Powered aircraft crash whilst taking off |
| accident aérien lors de l'atterrissage, passager d'un vaisseau spatial blessé |
Powered aircraft crash whilst landing |
| Water or air transport accident (event) |
Water transport accident (event) |
| Water or air transport accident (event) |
Air and space transport accident |
| Animal-drawn vehicle accident involving being thrown from animal-drawn vehicle, occupant of tram injured (event) |
Thrown from animal-drawn vehicle (event) |
| Animal-drawn vehicle accident involving being thrown from animal-drawn vehicle, pedestrian injured (event) |
Thrown from animal-drawn vehicle (event) |
| Animal-drawn vehicle accident involving being knocked down by animal-drawn vehicle, occupant of tram injured (event) |
Knocked down by animal-drawn vehicle (event) |
| Animal-drawn vehicle accident involving being knocked down by animal-drawn vehicle, occupant of animal-drawn vehicle injured (event) |
Knocked down by animal-drawn vehicle (event) |
| Animal-drawn vehicle accident involving being run over by animal-drawn vehicle, occupant of tram injured (event) |
Run over by animal-drawn vehicle (event) |
| Animal-drawn vehicle accident involving being run over by animal-drawn vehicle, pedestrian injured (event) |
Run over by animal-drawn vehicle (event) |
| Animal-drawn vehicle accident involving breakage of any part of vehicle, occupant of tram injured (event) |
Accident due to breakage of part of animal-drawn vehicle (event) |
| Animal-drawn vehicle accident involving fall from animal-drawn vehicle, rider of animal injured (event) |
Fall from animal-drawn vehicle (event) |
| Animal-drawn vehicle accident involving fall from animal-drawn vehicle, occupant of tram injured (event) |
Fall from animal-drawn vehicle (event) |
| Animal-drawn vehicle accident involving fall from animal-drawn vehicle, pedestrian injured (event) |
Fall from animal-drawn vehicle (event) |
| Animal-drawn vehicle accident involving collision between animal-drawn vehicle and animal, rider of animal injured (event) |
collision entre un véhicule à traction animale et un animal non-monté |
| Animal-drawn vehicle accident involving collision between animal-drawn vehicle and animal, occupant of tram injured (event) |
collision entre un véhicule à traction animale et un animal non-monté |
| Animal-drawn vehicle accident involving collision between animal-drawn vehicle and animal, pedestrian injured (event) |
collision entre un véhicule à traction animale et un animal non-monté |
| Animal-drawn vehicle accident involving collision between animal-drawn vehicle and pedestrian, pedestrian conveyance or pedestrian vehicle, rider of animal injured (event) |
Animal-drawn vehicle accident (event) |
| Animal-drawn vehicle accident involving collision between animal-drawn vehicle and nonmotor road vehicle except pedal cycle (event) |
Animal-drawn vehicle accident (event) |
| Animal-drawn vehicle accident involving collision between animal-drawn vehicle and nonmotor road vehicle except pedal cycle, rider of animal injured (event) |
Collision between animal-drawn vehicle and nonmotor road vehicle (event) |
| Animal-drawn vehicle accident involving collision between animal-drawn vehicle and nonmotor road vehicle except pedal cycle, occupant of tram injured (event) |
Collision between animal-drawn vehicle and nonmotor road vehicle (event) |
| Animal-drawn vehicle accident involving collision between animal-drawn vehicle and nonmotor road vehicle except pedal cycle, occupant of animal-drawn vehicle injured (event) |
Collision between animal-drawn vehicle and nonmotor road vehicle (event) |
| Animal-drawn vehicle accident involving collision between animal-drawn vehicle and nonmotor road vehicle except pedal cycle, pedestrian injured (event) |
Collision between animal-drawn vehicle and nonmotor road vehicle (event) |
| Accident in alighting from aircraft, occupant of spacecraft injured (event) |
accident en descendant d'un avion |
| Accident & emergency (qualifier value) |
Emergency medicine (qualifier value) |
| accident impliquant un véhicule de transport terrestre |
accident de la route avec un véhicule motorisé |
| accident non routier avec une chute à la montée ou la descente d'un véhicule motorisé, pas un véhicule tout terrain et pas sur une voie publique |
Motor vehicle accident off public road (event) |
| Accident in boarding aircraft, occupant of spacecraft injured (event) |
accident à l'embarquement d'un avion |
| accidents liés au transport ferroviaire et routier |
Railway accident |
| Failed minimum access approach (situation) |
Failed procedure using minimal access approach (situation) |
| Unilateral acheiria |
Congenital absence of left hand |
| Unilateral acheiria |
Congenital absence of right hand |
| Aminosalicylic acid |
Para-aminosalicylate |
| Aminosalicylic acid |
Para-aminosalicylic acid |
| Tranexamic acid 100mg/mL injection solution ampule (product) |
Tranexamic acid 100 mg/mL solution for injection |
| acné chéloïde |
acné chéloïdienne |
| acné chéloïde |
Keloid acne scar (disorder) |
| Colloid acne |
acné |
| Cetrorelix 0.25mg powder and solvent for injection solution vial (product) |
Product containing precisely cetrorelix (as cetrorelix acetate) 250 microgram/1 vial powder for conventional release solution for injection (clinical drug) |
| Cetrorelix 3mg powder and solvent for injection solution vial (product) |
Cetrorelix (as cetrorelix acetate) 3 mg powder for solution for injection vial |
| Desmopressin acetate 4micrograms/mL injection solution 1mL ampule (product) |
Desmopressin acetate 4 microgram/mL solution for injection |
| Flecainide acetate 10mg/mL injection solution 15mL ampule (product) |
Product containing precisely flecainide acetate 10 milligram/1 milliliter conventional release solution for injection (clinical drug) |
| Medroxyprogesterone acetate 150mg/mL injection suspension 1mL prefilled syringe (product) |
Product containing precisely medroxyprogesterone acetate 150 milligram/1 milliliter conventional release suspension for injection (clinical drug) |
| Methylprednisolone acetate 40mg/mL injection suspension 1mL vial (product) |
Methylprednisolone acetate 40 mg/mL suspension for injection |
| Methylprednisolone acetate 40mg/mL injection suspension 2mL vial (product) |
Methylprednisolone acetate 40 mg/mL suspension for injection |
| Methylprednisolone acetate 40mg/mL injection suspension 3mL vial (product) |
Methylprednisolone acetate 40 mg/mL suspension for injection |
| Methylprednisolone acetate+lidocaine hydrochloride 40/10mg/1mL injection (product) |
Product containing precisely lidocaine hydrochloride 10 milligram/1 milliliter and methylprednisolone acetate 40 milligram/1 milliliter conventional release suspension for injection (clinical drug) |
| Methylprednisolone acetate+lidocaine hydrochloride 80/20mg/2mL injection (product) |
Product containing precisely lidocaine hydrochloride 10 milligram/1 milliliter and methylprednisolone acetate 40 milligram/1 milliliter conventional release suspension for injection (clinical drug) |
| Zuclopenthixol acetate 50mg/mL injection solution 1mL ampule (product) |
Product containing precisely zuclopenthixol acetate 50 milligram/1 milliliter conventional release solution for injection (clinical drug) |
| Zuclopenthixol acetate 50mg/mL injection solution 2mL ampule (product) |
Product containing precisely zuclopenthixol acetate 50 milligram/1 milliliter conventional release solution for injection (clinical drug) |
| Triamcinolone acetonide 40mg/mL injection suspension 1mL prefilled syringe (product) |
Product containing precisely triamcinolone acetonide 40 milligram/1 milliliter conventional release suspension for injection (clinical drug) |
| Triamcinolone acetonide 40mg/mL injection suspension 2mL prefilled syringe (product) |
Product containing precisely triamcinolone acetonide 40 milligram/1 milliliter conventional release suspension for injection (clinical drug) |
| Medication administration: skin (procedure) |
Administration of drug or medicament to skin via topical route (procedure) |
| Medication administration: interpleural (procedure) |
Administration of drug or medicament via intrapleural route (procedure) |
| Adenosine 3mg/mL injection solution 2mL vial (product) |
Product containing precisely adenosine 3 milligram/1 milliliter conventional release solution for injection (clinical drug) |
| Subcutaneous tissue disease associated with AIDS |
trouble lié au SIDA |
| Subcutaneous tissue disease associated with AIDS |
Disorder of subcutaneous tissue (disorder) |
| Condition not suspected (situation) |
Clinical finding not suspected (situation) |
| Disorder of pelvic region (disorder) |
Disorder of pelvis |
| Disorder of pelvic region (disorder) |
Disorder of pelvic region of trunk (disorder) |
| Suspected condition |
Suspected clinical finding (situation) |
| Product containing anti-infective (product) |
Medicinal product acting as antiinfective agent (product) |
| Otic anti-infective agent (substance) |
Product manufactured as otic dose form (product) |
| Antiplatelet agent (substance) |
Platelet aggregation inhibitor |
| Biological agent |
produit pharmaceutique ou biologique |
| agent biologique |
Biological substance |
| Chelating agent / antidote (substance) |
Chelating agent |
| Chelating agent / antidote (substance) |
Antidote (substance) |
| Monoclonal antibody agent (substance) |
Monoclonal antibody (substance) |
| Miscellaneous agent |
Drug or medicament (substance) |
| Enzyme agent (substance) |
Enzyme |
| Ophthalmic agent (substance) |
produit pharmaceutique ou biologique |
| agent potassique topique |
Product containing potassium in cutaneous dose form (medicinal product form) |
| Throat agent (substance) |
produit pharmaceutique ou biologique |
| agent pour le traitement de la migraine |
Medicinal product acting as antimigraine agent (product) |
| agent topique au zinc |
Product containing zinc in cutaneous dose form (medicinal product form) |
| agent topique circulatoire |
produit pharmaceutique ou biologique |
| agent utilisé en médecine homéopathique |
Homeopathic medicine (product) |
| Nicotine agent (substance) |
Nicotine |
| agent à base de toxine de Clostridium botulinum |
anatoxine botulinique |
| agent à base de xanthine |
Xanthine and/or xanthine derivative (substance) |
FHIR